Estrogen receptor β sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 12, 2013, Pages 4708-4713

  Mak, Paul ^a   Chang, Cheng ^a   Pursell, Bryan ^a   Mercurio, Arthur M ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGENASE; PROLYL HYDROXYLASE 2; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CELL DIFFERENTIATION; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; HYDROXYLATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

CELL DIFFERENTIATION; CELL LINE, TUMOR; EPITHELIAL CELLS; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MUTATION; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEIN STABILITY; PROTEOLYSIS; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 84875243833     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1221654110     Document Type: Article

References (46)

1. Tsai MJ, O'Malley BW (1994) Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
2. Morani A, Warner M, Gustafsson JA (2008) Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med 264 (2):128-142.
3. Kumar MV, Tindall DJ (1998) Transcriptional regulation of the steroid receptor genes. Prog Nucleic Acid Res Mol Biol 59:289-306.
4. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA (1996) Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93(12): 5925-5930.
5. Kuiper GG, Gustafsson JA (1997) The novel estrogen receptor-beta subtype: Potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett 410(1):87-90.
6. Prins GS, et al. (1998) Estrogen receptor-beta messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139(3): 874-883.
7. Herynk MH, Fuqua SA (2007) Estrogen receptors in resistance to hormone therapy. Adv Exp Med Biol 608:130-143.
8. Lau KM, LaSpina M, Long J, Ho SM (2000) Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: Regulation by methylation and involvement in growth regulation. Cancer Res 60(12):3175-3182.
9. Mak P, et al. (2010) ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: Implications for Gleason grading. Cancer Cell 17(4):319-332.
10. Thomas C, et al. (2012) ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res 14(6):R148.
11. Thomas C, Gustafsson JA (2012) Targeting PES1 for restoring the ERa/ERβ ratio in breast cancer. J Clin Invest 122(8):2771-2773.
12. Imamov O, et al. (2004) Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate. Proc Natl Acad Sci USA 101(25):9375-9380.
13. Dondi D, et al. (2010) Estrogen receptor beta and the progression of prostate cancer: Role of 5alpha-androstane-3beta, 17beta-diol. Endocr Relat Cancer 17(3):731-742.
14. Leav I, et al. (2001) Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 159(1):79-92.
15. Weihua Z, Lathe R, Warner M, Gustafsson JA (2002) An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta, 17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99(21):13589-13594.
16. Guerini V, et al. (2005) The androgen derivative 5alpha-androstane-3beta, 17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res 65(12):5445-5453.
17. Muthusamy S, et al. (2011) Estrogen receptor β and 17β-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. Proc Natl Acad Sci USA 108(50):20090-20094.
18. Higgins DF, et al. (2007) Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117(12):3810-3820.
19. Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U (2008) Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 105(17):6392-6397.
20. Yang MH, et al. (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10(3):295-305.
21. Loda M, Kaelin WG, Jr. (2010) Prostate cancer: Beta control your hormones. Cancer Cell 17(4):311-312.
22. Kaelin WG, Jr., Ratcliffe PJ (2008) Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell 30(4):393-402.
23. Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40(2):294-309.
24. Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148(3): 399-408.
25. Kaelin WG, Jr. (2010) New cancer targets emerging from studies of the Von Hippel- Lindau tumor suppressor protein. Ann N Y Acad Sci 1210:1-7.
26. Berthon P, Cussenot O, Hopwood L, Leduc A, Maitland N (1995) Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells: Differentiation pattern of nontumorigenic cell-lines. Int J Oncol 6(2):333-343.
27. Debnath J, Brugge JS (2005) Modelling glandular epithelial cancers in threedimensional cultures. Nat Rev Cancer 5(9):675-688.
28. Gibbons DL, et al. (2009) Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev 23(18):2140-2151.
29. Ocaña OH, et al. (2012) Metastatic colonization requires the repression of the epithelial- mesenchymal transition inducer Prrx1. Cancer Cell 22(6):709-724.
30. Kozlowski JM, et al. (1984) Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 44(8):3522-3529.
31. Elvidge GP, et al. (2006) Concordant regulation of gene expression by hypoxia and 2- oxoglutarate-dependent dioxygenase inhibition: The role of HIF-1alpha, HIF-2alpha, and other pathways. J Biol Chem 281(22):15215-15226.
32. Leite de Oliveira R, et al. (2012) Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity. Cancer Cell 22(2):263-277.
33. Bates RC, et al. (2003) Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr Biol 13(19):1721-1727.
34. Goel HL, et al. (2012) VEGF/neuropilin-2 regulation of Bmi-1 and consequent repression of IGF-IR define a novel mechanism of aggressive prostate cancer. Cancer Discov 2(10):906-921.
35. Yang AD, et al. (2006) Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells. Cancer Res 66(1):46-51.
36. Lichtenberger BM, et al. (2010) Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell 140(2):268-279.
37. Garcia-Parra R, et al. (2011) Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques. Eur J Nucl Med Mol Imaging 38(10):1816-1823.
38. Vivar OI, et al. (2010) Estrogen receptor beta binds to and regulates three distinct classes of target genes. J Biol Chem 285(29):22059-22066.
39. Grober OM, et al. (2011) Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation. BMC Genomics 12:36.
40. Zhao C, et al. (2010) Genome-wide mapping of estrogen receptor-beta-binding regions reveals extensive cross-talk with transcription factor activator protein-1. Cancer Res 70(12):5174-5183.
41. Zhang Q, et al. (2009) Control of cyclin D1 and breast tumorigenesis by the EglN2 prolyl hydroxylase. Cancer Cell 16(5):413-424.
42. Mazzone M, et al. (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136(5):839-851.
43. Mani SA, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4):704-715.
44. Bos R, et al. (2001) Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 93(4):309-314.
45. Shen C, et al. (2011) Genetic and functional studies implicate HIF1a as a 14q kidney cancer suppressor gene. Cancer Discov 1(3):222-235.
46. Tian B, Yang J, Brasier AR (2012) Two-step cross-linking for analysis of protein- chromatin interactions. Methods Mol Biol 809:105-120.